Skip to main content

BLTE · Belite Bio, Inc · Proposed Sales

Track BLTE — free
$159.18 -0.38 (-0.24%)
Market Cap
$6.71B
Shares
40.27M
Volume · Oct 5 133.29K Avg daily vol (3M) 184.04K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-10-17 Wan Shan Chen 9,550
2025-10-16 Wan Shan Chen 1,050
2025-10-14 Wan Shan Chen 1,050
2025-10-14 Hao-Yuan Chuang 70,054
2025-09-18 Yu-Hsin Lin 96,950
2025-08-21 Nathan L. Mata 30,000
2025-05-21 Yu-Hsin Lin 120,400
2025-03-19 Nathan Mata 30,166
2025-01-02 Hao-Yuan Chuang 160,000
2025-01-02 Yu-Hsin Lin 162,000
2024-11-20 Wei-Cheng Liaw 5,999
2024-11-19 Nathan Mata 30,000
2024-10-03 Yu-Hsin Lin 40,000
2024-10-03 Hao-Yuan Chuang 40,000
2024-09-20 Wei-Cheng Liaw 6,500
2024-09-04 Wan Shan Chen 6,650
2024-08-16 Nathan Mata 30,000
2024-08-14 Yu-Hsin Lin 100,000
2024-08-14 Chiu, Ching Chen 34,568
2024-08-14 Hao-Yuan Chuang 100,000
2024-06-04 Nathan Mata 30,000
2024-05-30 Yu-Hsin Lin 50,000
2024-05-30 Hao-Yuan Chuang 50,000
2024-05-17 Nathan Mata 15,000
2024-05-16 Ching Chen Chiu 35,000
2024-03-22 Wan-Shan Chen 10,000
2024-03-14 Nathan Mata 6,000
2023-12-28 Hao-Yuan Chuang 100,000
2023-12-28 Yu-Hsin Lin 100,000
2023-11-28 Wan-Shan Chen 6,000
2023-11-16 Yu-Hsin Lin 100,000
2023-11-16 Hao-Yuan Chuang 100,000
2023-08-31 Hao-Yuan Chuang 50,000
2023-08-31 Yu-Hsin Lin 50,000
Showing 1–34 of 34 filings
Key facts CIK 1889109 CUSIP 07782B104 13F (30d) 2 filings 2 filers Visit website Investor relations